Coller Crile Forceps Curved
14-20 Days
Original price was: $ 63.04.$ 56.74Current price is: $ 56.74.
Coller Crile Curved Forceps are hemostatic surgical instruments used to clamp blood vessels or tissues, featuring curved jaws with serrations along their full length for secure and precise control.
-
Purpose: Clamping blood vessels and controlling bleeding.
-
Jaw Design: Curved, fully serrated jaws for secure grip.
-
Locking: Ratchet mechanism for consistent pressure control.
-
Material: Surgical-grade stainless steel.
-
Applications: General surgery, gynecology, cardiovascular, soft tissue handling.
-
Length: Commonly 6.25″ to 6.5″ (approx. 16 cm).
-
Sterilization: Autoclavable and reusable.
-
Ergonomics: Finger ring handles for precision and comfort.
Fast Shipping & 30-Days
hassle-free returns & exchanges
Your Order is Protected,
Free Replacement Guaranteed
Enjoy substantial savings with our discounts rates & reasonable pricing.
Safe & secure payments
via debit/credit card
Related products
Forceps
Forceps
Coller Crile Forceps (Curved) are versatile hemostatic instruments commonly used in surgical procedures to clamp blood vessels, control bleeding, or handle soft tissue. These forceps are a variant of standard Crile forceps but often include subtle modifications for improved handling or specific surgical preferences, sometimes referred to by regional or manufacturer-specific names like “Coller.”
The curved jaws of the instrument are fully serrated, providing a secure grip along the entire length of the tissue or vessel. This design is particularly useful in deeper surgical fields where better visibility and access are needed. The ratchet locking mechanism on the handles allows the surgeon to lock the forceps in place for consistent pressure during ligation or dissection.
Made from high-quality surgical-grade stainless steel, Coller Crile Forceps are durable, corrosion-resistant, and autoclavable. They are widely used in general, gynecological, cardiovascular, and other types of surgeries.
Reviews
There are no reviews yet.